Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
Open accessThe DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.
Abstract
Colorectal cancer is one of the most common causes of cancer death worldwide. In patients with metastatic colorectal cancer, combination treatment with several anti-cancer drugs is employed and improves overall survival in some patients. Nevertheless, most patients with metastatic disease are not cured owing to the drug resistance. Cancer stem cells are known to regulate resistance to chemotherapy. In the previous study, we established a novel three-dimensional organoid culture model from tumor colorectal tissues of human patients using an air–liquid interface (ALI) method, which contained numerous cancer stem cells and showed resistance to 5-fluorouracil (5-FU) and Irinotecan. Here, we investigate which inhibitor for stem cell-related signal improves the sensitivity for anti-cancer drug treatment in tumor ALI organoids. Treatment with Hedgehog signal inhibitors (AY9944, GANT61) decreases the cell viability of organoids compared with Notch (YO-01027, DAPT) and Wnt (WAV939, Wnt-C59) signal inhibitors. Combination treatment of AY9944 or GANT61 with 5-FU, Irinotecan or Oxaliplatin decreases the cell viability of tumor organoids compared with each anti-cancer drug alone treatment. Treatment with AY9944 or GANT61 inhibits expression of stem cell markers c-Myc, CD44 and Nanog, likely through the decrease of their transcription factor, GLI-1 expression. Combination treatment of AY9944 or GANT61 with 5-FU or Irinotecan also prevents colony formation of colorectal cancer cell lines HCT116 and SW480. These findings suggest that Hedgehog signals mediate anti-cancer drug resistance in colorectal tumor patient-derived ALI organoids and that the inhibitors are useful as a combinational therapeutic strategy against colorectal cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Nevertheless, inhibiting Hh signaling in CRC cells has been shown to be effective in reducing cell viability and expression of CSC markers and may also enhance chemosensitivity at least in some cellular contexts [200,201,202].”
From Mechanisms and Strategies to Overcome Drug Resistance in Colorectal Cancer (2025) · cites this paper as [200]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Olive, K. P., Jacobetz, M. A., Davidson, C. J., Gopinathan, A., McIntyre, D., Honess, D., Madhu, B., Goldgraben, M. A., Caldwell, M. E., Allard, D., et al. (2009) · Science · doi:10.1126/science.1171362 · Cited by 3,170
Hedgehog signaling in animal development: paradigms and principles
Ingham, P. W., & McMahon, A. P. (2001) · Genes & Development · doi:10.1101/gad.938601 · Cited by 2,985
A distinct “side population” of cells with high drug efflux capacity in human tumor cells
Hirschmann-Jax, C., Foster, A. E., Wulf, G. G., Nuchtern, J. G., Jax, T. W., Gobel, U., Goodell, M. A., & Brenner, M. K. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0400067101 · Cited by 1,280
Sustained in vitro intestinal epithelial culture within a Wnt-dependent stem cell niche
Ootani, A., Li, X., Sangiorgi, E., Ho, Q. T., Ueno, H., Toda, S., Sugihara, H., Fujimoto, K., Weissman, I. L., Capecchi, M. R., et al. (2009) · Nature Medicine · doi:10.1038/nm.1951 · Cited by 906
Smoothened Mutation Confers Resistance to a Hedgehog Pathway Inhibitor in Medulloblastoma
Yauch, R. L., Dijkgraaf, G. J. P., Alicke, B., Januario, T., Ahn, C. P., Holcomb, T., Pujara, K., Stinson, J., Callahan, C. A., Tang, T., et al. (2009) · Science · doi:10.1126/science.1179386 · Cited by 839
Small-molecule antagonists of the oncogenic Tcf/β-catenin protein complex
Lepourcelet, M., Chen, Y.-N. P., France, D. S., Wang, H., Crews, P., Petersen, F., Bruseo, C., Wood, A. W., & Shivdasani, R. A. (2004) · Cancer Cell · doi:10.1016/s1535-6108(03)00334-9 · Cited by 653
Cancer Stem Cells in Radiation Resistance
Rich, J. N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0895 · Cited by 496
Varnat, F., Duquet, A., Malerba, M., Zbinden, M., Mas, C., Gervaz, P., & Ruiz i Altaba, A. (2009) · EMBO Molecular Medicine · doi:10.1002/emmm.200900039 · Cited by 463
Colon Cancer Stem Cells: Promise of Targeted Therapy
Todaro, M., Francipane, M. G., Medema, J. P., & Stassi, G. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.063 · Cited by 443
Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture
Li, X., Nadauld, L., Ootani, A., Corney, D. C., Pai, R. K., Gevaert, O., Cantrell, M. A., Rack, P. G., Neal, J. T., Chan, C. W.-M., et al. (2014) · Nature Medicine · doi:10.1038/nm.3585 · Cited by 442
Hedgehog signaling is restricted to the stromal compartment during pancreatic carcinogenesis
Tian, H., Callahan, C. A., DuPree, K. J., Darbonne, W. C., Ahn, C. P., Scales, S. J., & de Sauvage, F. J. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0813203106 · Cited by 404
DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency
Hoey, T., Yen, W.-C., Axelrod, F., Basi, J., Donigian, L., Dylla, S., Fitch-Bruhns, M., Lazetic, S., Park, I.-K., Sato, A., et al. (2009) · Cell Stem Cell · doi:10.1016/j.stem.2009.05.019 · Cited by 398
Combined Targeted Treatment to Eliminate Tumorigenic Cancer Stem Cells in Human Pancreatic Cancer
Mueller, M., Hermann, P. C., Witthauer, J., Rubio–Viqueira, B., Leicht, S. F., Huber, S., Ellwart, J. W., Mustafa, M., Bartenstein, P., D'Haese, J. G., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.05.053 · Cited by 348
Cancer stem cells: implications for the progression and treatment of metastatic disease
Croker, A. K., & Allan, A. L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00211.x · Cited by 273
Systematic reviews of chemotherapy and endocrine therapy in metastatic breast cancer
Stockler, M., Wilcken, N. R. C., Ghersi, D., & Simes, R. J. (2000) · Cancer Treatment Reviews · doi:10.1053/ctrv.1999.0161 · Cited by 218
Identification of CD44+CD24+ gastric cancer stem cells
Zhang, C., Li, C., He, F., Cai, Y., & Yang, H. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1038-5 · Cited by 216
Clinical Experience With Hedgehog Pathway Inhibitors
Low, J. A., & de Sauvage, F. J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.27.9943 · Cited by 175
Molecular Pathways: The Hedgehog Signaling Pathway in Cancer
McMillan, R. H., & Matsui, W. H. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-2509 · Cited by 170
Fujiwara, N., Usui, T., Ohama, T., & Sato, K. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.704908 · Cited by 99
Self-citationInhibition of the Hedgehog Pathway Targets the Tumor-Associated Stroma in Pancreatic Cancer
Hwang, R. F., Moore, T. T., Hattersley, M. M., Scarpitti, M., Yang, B., Devereaux, E., Ramachandran, V., Arumugam, T., Ji, B., Logsdon, C. D., et al. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0022 · Cited by 97
Colon cancer stem cells: implications for prevention and therapy
Huang, E. H., & Wicha, M. S. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.09.005 · Cited by 86
Aberrant GLI1 Activation in DNA Damage Response, Carcinogenesis and Chemoresistance
Palle, K., Mani, C., Tripathi, K. K., & Athar, M. (2015) · Cancers · doi:10.3390/cancers7040894 · Cited by 77
Self-renewal molecular mechanisms of colorectal cancer stem cells
Pan, T., Xu, J., & Zhu, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2815 · Cited by 60
Batsaikhan, B.-E., Yoshikawa, K., Kurita, N., Iwata, T., Takasu, C., Kashihara, H., & Shimada, M. (2014) · PubMed · Cited by 59
Yang, Z., Cui, Y. R., Ni, W., Kim, S., & Xuan, Y. (2016) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-016-2273-6 · Cited by 58
Usui, T., Sakurai, M., Enjoji, S., Kawasaki, H., Umata, K., Ohama, T., Fujiwara, N., Yabe, R., Tsuji, S., Yamawaki, H., et al. (2016) · Stem Cells International · doi:10.1155/2016/7053872 · Cited by 57
Self-citationTolba, M. F., & Abdel-Rahman, S. Z. (2015) · Scientific Reports · doi:10.1038/srep15239 · Cited by 55
The role of GLI1 for 5-Fu resistance in colorectal cancer
Zhang, L., Song, R., Gu, D., Zhang, X., Yu, B., Liu, B., & Xie, J. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0145-7 · Cited by 50
Intestinal stem cells and the colorectal cancer microenvironment
Ong, B. A., Vega, K. J., & Houchen, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i8.1898 · Cited by 49
Liver Metastases From Colorectal Cancer: The Turning Point
Nordlinger, B., & Rougier, P. R. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.6.1442 · Cited by 49
Agyeman, A., Mazumdar, T., & Houghton, J. A. (2012) · Oncotarget · doi:10.18632/oncotarget.586 · Cited by 45
Stromal Indian Hedgehog Signaling Is Required for Intestinal Adenoma Formation in Mice
Büller, N. V. J. A., Rosekrans, S. L., Metcalfe, C., Heijmans, J., van Dop, W. A., Fessler, E., Jansen, M., Ahn, C. P., Vermeulen, J. L. M., Westendorp, B. F., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.006 · Cited by 42
Yabe, R., Miura, A., Usui, T., Mudrak, I., Ogris, E., Ohama, T., & Sato, K. (2015) · PLOS ONE · doi:10.1371/journal.pone.0145226 · Cited by 37
Self-citationCancer Stem Cells – Are Surface Markers Alone Sufficient?
Nagare, R. P., Sneha, S., Priya, S. K., & Ganesan, T. S. (2016) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x11666160607211436 · Cited by 35
Kake, S., Usui, T., Ohama, T., Yamawaki, H., & Sato, K. (2017) · Oncology Reports · doi:10.3892/or.2017.5359 · Cited by 34
Self-citationGalimberti, F., Busch, A. M., Chinyengetere, F., Ma, T., Sekula, D., Memoli, V. A., Dragnev, K. H., Liu, F., Johnson, K. C., Guo, Y., et al. (2012) · International Journal of Oncology · doi:10.3892/ijo.2012.1599 · Cited by 21
Lenz, H. (2008) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(08)70002-1 · Cited by 13
Cited by
El-Husseiny, H. M., Mady, E. A., Hamabe, L., Abugomaa, A., Shimada, K., Yoshida, T., Tanaka, T., Yokoi, A., Elbadawy, M., & Tanaka, R. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100186 · Cited by 533
Self-citationOrganoid technology and applications in cancer research
Xu, H., Lyu, X., Yi, M., Zhao, W., Song, Y., & Wu, K. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-018-0662-9 · Cited by 345
Kumar, V., Vashishta, M., Kong, L., Wu, X., Lu, J. J., Guha, C., & Dwarakanath, B. S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.650772 · Cited by 255
Elbadawy, M., Usui, T., Yamawaki, H., & Sasaki, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092340 · Cited by 234
Self-citationThe Roles of Cancer Stem Cells and Therapy Resistance in Colorectal Carcinoma
Das, P. K., Islam, F., & Lam, A. K. (2020) · Cells · doi:10.3390/cells9061392 · Cited by 210
Metadata
- Authors
- Usui, T., Sakurai, M., Umata, K., Elbadawy, M., Ohama, T., Yamawaki, H., Hazama, S., Takenouchi, H., Nakajima, M., Tsunedomi, R., Suzuki, N., Nagano, H., Sato, K., Kaneda, M., & Sasaki, K.
- Affiliations
- Tokyo University of Agriculture and Technology (JP)
- Yamaguchi University (JP)
- Benha University (EG)
- Kitasato University (JP)
- Corresponding author
- Usui, Tatsuya
- ORCID
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2018-04-06
- Volume
- 19
- Issue
- 4
- Pages
- 1098
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC5979580
- OpenAlex
- W2796200410
- Cited by
- 96
- References
- 39
- Citations by year
- 2026: 3 · 2025: 13 · 2024: 10 · 2023: 7 · 2022: 23 · 2021: 15 · 2020: 16 · 2019: 6 · 2018: 3
- FWCI
- 3.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Japan Society for the Promotion of Science (16K10574)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Hedgehog Signaling Pathway Studies
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- Hedgehog signaling, drug resistance, colorectal cancer, cancer stem cells, organoid culture, air-liquid interface, 5-fluorouracil, irinotecan, oxaliplatin, Hedgehog pathway inhibitors, AY-9944, GANT61, Gli1, c-Myc, CD44, Nanog, combination therapy, patient-derived tumor organoids
- MeSH terms
- Zinc Finger Protein GLI1, Irinotecan, Oxaliplatin, trans-1,4-Bis(2-chlorobenzaminomethyl)cyclohexane Dihydrochloride, Camptothecin, Fluorouracil, Humans, Organoids, Organoplatinum Compounds, Pyridines, Pyrimidines, Neoplastic Stem Cells, Colorectal Neoplasms, Proto-Oncogene Proteins c-myc, Hyaluronan Receptors, Drug Resistance, Neoplasm, HCT116 Cells, Hedgehog Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.